Insider Transactions Reported by 11 Insiders of Histogen Inc.

Location
San Diego, CA

Quick Takeaways

  • Histogen Inc. has 11 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are not currently available.

What Changed

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Why This Matters

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 22 Apr 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Histogen Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Daniel L. Kisner Director Mixed 20 Jun 2023
Brian Satz Director Mixed 20 Jun 2023
Jonathan Jackson Director Mixed 20 Jun 2023
Susan A. Knudson COO and CFO Mixed 10 Mar 2023
Martin Latterich SVP, Technical Operations Mixed 17 Feb 2022
Joyce Reyes Officer Mixed 10 Mar 2023
Rochelle Fuhrmann Director Mixed 20 Jun 2023
Richards Windham Bannister Director Mixed 20 Jun 2023
Ph.D. Alfred P. Spada Executive Vice President and Chief Scientific Officer Mixed 23 Feb 2023
Steven J. Mento President and CEO, Director Mixed 10 Mar 2023
David H. Crean Director Mixed 20 Jun 2023

Top shareholders of Histogen Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Martin Latterich
3/4/5
SVP, Technical Operations —
class O/S missing
134,900
 — — 17 Feb 2022
3/4/5
Ph.D. Alfred P. Spada
3/4/5
Executive Vice President and Chief Scientific Officer —
mixed-class rows
109,007
mixed-class rows
 — — 23 Feb 2023
3/4/5
Brian Satz
3/4/5
Director —
class O/S missing
6,835
 — — 20 Jun 2023
3/4/5
Daniel L. Kisner
3/4/5
Director —
class O/S missing
6,835
 — — 20 Jun 2023
3/4/5
David H. Crean
3/4/5
Director —
class O/S missing
6,835
 — — 20 Jun 2023
3/4/5
Jonathan Jackson
3/4/5
Director —
class O/S missing
6,835
 — — 20 Jun 2023
3/4/5
Richards Windham Bannister
3/4/5
Director —
class O/S missing
6,835
 — — 20 Jun 2023
3/4/5
Rochelle Fuhrmann
3/4/5
Director —
class O/S missing
6,835
 — — 20 Jun 2023
3/4/5

Recent Insider Transactions by Companies or Individuals for Histogen Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.